The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer
Launched by ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY · Oct 30, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The PLATINUM Trial is a clinical study looking at how effective a new chemotherapy treatment is for patients with advanced pancreatic cancer that has spread to other parts of the body. Specifically, the trial is comparing a combination of three drugs (nab-paclitaxel, gemcitabine, and cisplatin) against a combination of two drugs (nab-paclitaxel and gemcitabine). This trial is aimed at patients who have specific genetic mutations (BRCA1, BRCA2, or PALB2) and who have already received other treatments that didn’t work.
To be eligible for this trial, participants need to be at least 18 years old and have a type of pancreatic cancer that has spread. They must also have a known genetic mutation and measurable cancer, meaning the cancer can be tracked with tests. Participants will receive the new chemotherapy treatment and be monitored closely for its effects. This trial is currently recruiting new patients, and it offers a chance to contribute to important research that may improve future treatments for pancreatic cancer.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Metastatic pancreatic adenocarcinoma. Adenosquamous carcinoma, squamous carcinoma, acinar cell carcinoma, and carcinoma not otherwise specified are also acceptable
- • BRCA1/2 or PALB2 mutation (somatic or germline) identified on any Clinical Laboratory Improvement Amendments (CLIA)-certified gene panel. Mutations must be considered pathogenic or likely pathogenic by a reference database such as ClinVar or OncoKb.org. (Submission of mutation report will be required)
- • Measurable disease
- • Potential trial participants should have recovered from clinically significant adverse events of their most recent therapy/intervention prior to enrollment
- • Clinical or radiographic progression on first-line FOLFIRINOX (or nanoliposomal irinotecan, fluorouracil, leucovorin, and oxaliplatin \[NALIRIFOX\]) for metastatic disease
- • Patients whose front-line chemotherapy was required to be simplified due to toxicity associated with any of the constituent components of FOLFIRINOX/NALIRIFOX (e.g. simplified to leucovorin calcium, fluorouracil, and oxaliplatin \[FOLFOX\], leucovorin calcium, fluorouracil, and irinotecan \[FOLFIRI\], fluorouracil \[5-FU\] \[including capecitabine\]) will be eligible
- • Patients with progressive disease while on maintenance PARP inhibitor treatment after FOLFIRINOX (or NALIRIFOX), irrespective of how long ago they received FOLFIRINOX/NALIRIFOX, will also be eligible
- • Patients who develop metastatic disease during or within 6 months after completing FOLFIRINOX/NALIRIFOX in either the locally advanced or adjuvant/neoadjuvant settings will be eligible
- • Patients may not have received prior cisplatin for their pancreatic cancer in any setting
- • \* Note: Patients may have previously received gemcitabine +/- nab-paclitaxel for resectable (neoadjuvant/adjuvant) or locally advanced disease if (1) treatment was completed \> 1 year ago and (2) in the opinion of the treating provider, re-treatment with gemcitabine/nab-paclitaxel is appropriate
- • Age \>= 18 years
- • Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky performance status \>= 60)
- • Absolute neutrophil count \>= 1,500/mm\^3
- • Platelet count \>= 100,000/mm\^3
- • Hemoglobin \>= 8.0 g/dL
- • Creatinine =\< 1.8 x institutional upper limit of normal (ULN) or calculated creatinine clearance (Calc. CrCl) \> 40 mL/min
- • Total bilirubin =\< 2.0 x institutional ULN
- • \* Any elevated bilirubin should be asymptomatic at enrollment (except for participants with documented Gilbert's syndrome who may only be included if the total bilirubin =\< 3 x ULN or direct bilirubin =\< 1.5 x ULN)
- • Aspartate transaminase (AST)/alanine transaminase (ALT) =\< 3 x institutional ULN
- • \* AST/ALT of =\< 5 x ULN if liver metastases are present
- • Not pregnant and not nursing, because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects
- • \* Therefore, for women of childbearing potential only, a negative pregnancy test done =\< 14 days prior to registration is required
- • Patients with \> grade 2 peripheral sensory neuropathy are not eligible
- • Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
- • Patients with treated brain metastases are eligible if follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of progression for at least 8-weeks.
- • \* Patients with known, new or progressive brain metastases (active brain metastases) or leptomeningeal disease are ineligible
- • Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load anytime within 6 months prior to registration are eligible for this trial
- • For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated.
- • \* Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load
- • Concomitant chronic concomitant treatment with strong inhibitors of CYP3A4 is not allowed on this study. Patients on strong CYP3A4 inhibitors must discontinue the drug for 14 days prior to registration on the study
- • Chronic concomitant treatment with strong CYP3A4 inducers is not allowed. Patients must discontinue the drug 14 days prior to the start of study treatment
- Exclusion Criteria:
- • N/A
About Alliance For Clinical Trials In Oncology
The Alliance for Clinical Trials in Oncology is a prominent cooperative group dedicated to conducting high-quality, innovative clinical research aimed at improving cancer treatment and patient outcomes. Comprising a diverse network of institutions and investigators, the Alliance focuses on developing and implementing clinical trials that evaluate new therapies, treatment combinations, and prevention strategies across various cancer types. By fostering collaboration among oncologists, researchers, and healthcare professionals, the Alliance aims to accelerate the translation of scientific discoveries into effective clinical practices, ultimately enhancing the standard of care for cancer patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kalamazoo, Michigan, United States
Edina, Minnesota, United States
Waconia, Minnesota, United States
Harvey, Illinois, United States
Peoria, Illinois, United States
Detroit, Michigan, United States
Anchorage, Alaska, United States
Oklahoma City, Oklahoma, United States
Des Moines, Iowa, United States
Great Falls, Montana, United States
Saint Paul, Minnesota, United States
Ann Arbor, Michigan, United States
Kalamazoo, Michigan, United States
Traverse City, Michigan, United States
Bozeman, Montana, United States
Kalispell, Montana, United States
Sheridan, Wyoming, United States
Cincinnati, Ohio, United States
Dallas, Texas, United States
Coon Rapids, Minnesota, United States
Urbana, Illinois, United States
Minneapolis, Minnesota, United States
Saint Paul, Minnesota, United States
Shakopee, Minnesota, United States
Willmar, Minnesota, United States
Council Bluffs, Iowa, United States
Effingham, Illinois, United States
Longmont, Colorado, United States
Springfield, Illinois, United States
Cincinnati, Ohio, United States
Portland, Oregon, United States
Springfield, Illinois, United States
Honolulu, Hawaii, United States
Minneapolis, Minnesota, United States
Orange, California, United States
Honolulu, Hawaii, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
Duluth, Minnesota, United States
Saint Cloud, Minnesota, United States
Saint Louis, Missouri, United States
Kearney, Nebraska, United States
New York, New York, United States
Aurora, Illinois, United States
Tulsa, Oklahoma, United States
Centralia, Washington, United States
Cape Girardeau, Missouri, United States
Aventura, Florida, United States
Honolulu, Hawaii, United States
Coos Bay, Oregon, United States
Pueblo, Colorado, United States
Robbinsdale, Minnesota, United States
Saint Louis Park, Minnesota, United States
Omaha, Nebraska, United States
Memphis, Tennessee, United States
Omaha, Nebraska, United States
Omaha, Nebraska, United States
Glens Falls, New York, United States
Grand Rapids, Michigan, United States
Dallas, Texas, United States
San Francisco, California, United States
Marshfield, Wisconsin, United States
Honolulu, Hawaii, United States
Portland, Oregon, United States
Miami Beach, Florida, United States
Decatur, Illinois, United States
Ottawa, Illinois, United States
Peoria, Illinois, United States
Missoula, Montana, United States
Galesburg, Illinois, United States
Cedar Rapids, Iowa, United States
Cedar Rapids, Iowa, United States
Clive, Iowa, United States
Des Moines, Iowa, United States
Des Moines, Iowa, United States
Brainerd, Minnesota, United States
Duluth, Minnesota, United States
Duluth, Minnesota, United States
Lincoln, Nebraska, United States
Papillion, Nebraska, United States
Anchorage, Alaska, United States
Omaha, Nebraska, United States
Cape Girardeau, Missouri, United States
Peru, Illinois, United States
Adrian, Michigan, United States
Monroe, Michigan, United States
Maplewood, Minnesota, United States
Maplewood, Minnesota, United States
Stillwater, Minnesota, United States
Great Falls, Montana, United States
Maumee, Ohio, United States
Toledo, Ohio, United States
Kalamazoo, Michigan, United States
Bremerton, Washington, United States
Burbank, California, United States
'Aiea, Hawaii, United States
Honolulu, Hawaii, United States
Honolulu, Hawaii, United States
Honolulu, Hawaii, United States
Galesburg, Illinois, United States
Battle Creek, Michigan, United States
Grand Rapids, Michigan, United States
Saint Joseph, Michigan, United States
Woodbury, Minnesota, United States
Billings, Montana, United States
Missoula, Montana, United States
Vancouver, Washington, United States
Minocqua, Wisconsin, United States
Rice Lake, Wisconsin, United States
Weston, Wisconsin, United States
Colorado Springs, Colorado, United States
Lakewood, Colorado, United States
Bellingham, Washington, United States
Kennewick, Washington, United States
Sedro Woolley, Washington, United States
Kailua, Hawaii, United States
Clackamas, Oregon, United States
Newberg, Oregon, United States
Munster, Indiana, United States
New Ulm, Minnesota, United States
Albuquerque, New Mexico, United States
Boise, Idaho, United States
Council Bluffs, Iowa, United States
Canton, Illinois, United States
Carthage, Illinois, United States
Eureka, Illinois, United States
Kewanee, Illinois, United States
Macomb, Illinois, United States
Peru, Illinois, United States
Princeton, Illinois, United States
Boise, Idaho, United States
Fargo, North Dakota, United States
Walla Walla, Washington, United States
Grand Island, Nebraska, United States
Santa Rosa, California, United States
Post Falls, Idaho, United States
Bloomington, Illinois, United States
Pekin, Illinois, United States
Bend, Oregon, United States
Carmichael, California, United States
Omaha, Nebraska, United States
Longview, Washington, United States
Jonesboro, Arkansas, United States
Merced, California, United States
Lihue, Hawaii, United States
Fruitland, Idaho, United States
Meridian, Idaho, United States
Nampa, Idaho, United States
Twin Falls, Idaho, United States
Oregon City, Oregon, United States
Edmonds, Washington, United States
Everett, Washington, United States
Issaquah, Washington, United States
Lacey, Washington, United States
New Richmond, Wisconsin, United States
Springfield, Illinois, United States
Anchorage, Alaska, United States
Fairfax, Virginia, United States
Great Falls, Montana, United States
Caldwell, Idaho, United States
Coeur D'alene, Idaho, United States
Emmett, Idaho, United States
Meridian, Idaho, United States
Sandpoint, Idaho, United States
Clive, Iowa, United States
West Des Moines, Iowa, United States
Minneapolis, Minnesota, United States
Anaconda, Montana, United States
Baker City, Oregon, United States
Ontario, Oregon, United States
Cody, Wyoming, United States
Anchorage, Alaska, United States
Anchorage, Alaska, United States
Anchorage, Alaska, United States
Anchorage, Alaska, United States
Anchorage, Alaska, United States
Colorado Springs, Colorado, United States
Durango, Colorado, United States
Durango, Colorado, United States
Creston, Iowa, United States
Bardstown, Kentucky, United States
Corbin, Kentucky, United States
Lexington, Kentucky, United States
Lexington, Kentucky, United States
Cincinnati, Ohio, United States
Cincinnati, Ohio, United States
Aberdeen, Washington, United States
Seattle, Washington, United States
Shelton, Washington, United States
Yelm, Washington, United States
Carbondale, Illinois, United States
Carterville, Illinois, United States
Centralia, Illinois, United States
Decatur, Illinois, United States
Effingham, Illinois, United States
Mattoon, Illinois, United States
New Lenox, Illinois, United States
O'fallon, Illinois, United States
Yorkville, Illinois, United States
Novi, Michigan, United States
West Bloomfield, Michigan, United States
Maple Grove, Minnesota, United States
Wyoming, Minnesota, United States
Sainte Genevieve, Missouri, United States
Sullivan, Missouri, United States
Clackamas, Oregon, United States
Mount Vernon, Washington, United States
Seattle, Washington, United States
Ames, Iowa, United States
Norton Shores, Michigan, United States
Monticello, Minnesota, United States
Columbus, Mississippi, United States
Grenada, Mississippi, United States
New Albany, Mississippi, United States
Oxford, Mississippi, United States
Southhaven, Mississippi, United States
Eau Claire, Wisconsin, United States
Council Bluffs, Iowa, United States
Honolulu, Hawaii, United States
London, Kentucky, United States
'Aiea, Hawaii, United States
'Aiea, Hawaii, United States
Ashland, Wisconsin, United States
Orland Park, Illinois, United States
Aiea, Hawaii, United States
Phoenix, Arizona, United States
Elk Grove, California, United States
Rocklin, California, United States
Sacramento, California, United States
San Luis Obispo, California, United States
Santa Maria, California, United States
Woodland, California, United States
Seattle, Washington, United States
Fort Worth, Texas, United States
Stevens Point, Wisconsin, United States
Arroyo Grande, California, United States
Aitkin, Minnesota, United States
Deer River, Minnesota, United States
Hibbing, Minnesota, United States
Sandstone, Minnesota, United States
Virginia, Minnesota, United States
Collierville, Tennessee, United States
Ashland, Wisconsin, United States
Honolulu, Hawaii, United States
Redmond, Oregon, United States
Detroit Lakes, Minnesota, United States
Fosston, Minnesota, United States
Park Rapids, Minnesota, United States
Jamestown, North Dakota, United States
Brighton, Michigan, United States
Dixon, Illinois, United States
Washington, Illinois, United States
Farmington, Missouri, United States
Santa Rosa, California, United States
Colorado Springs, Colorado, United States
Burnsville, Minnesota, United States
Bozeman, Montana, United States
Cambridge, Minnesota, United States
Princeton, Minnesota, United States
Carmichael, California, United States
'Ewa Beach, Hawaii, United States
Honolulu, Hawaii, United States
Kahului, Hawaii, United States
Crown Point, Indiana, United States
Dyer, Indiana, United States
Hobart, Indiana, United States
Hobart, Indiana, United States
Indianapolis, Indiana, United States
Munster, Indiana, United States
Valparaiso, Indiana, United States
Kalamazoo, Michigan, United States
Baxter, Minnesota, United States
Ely, Minnesota, United States
International Falls, Minnesota, United States
Moose Lake, Minnesota, United States
Omaha, Nebraska, United States
Omaha, Nebraska, United States
Richardson, Texas, United States
Goodyear, Arizona, United States
Missoula, Montana, United States
Napa, California, United States
Hayward, Wisconsin, United States
Spooner, Wisconsin, United States
Superior, Wisconsin, United States
'Aiea, Hawaii, United States
Nampa, Idaho, United States
Springfield, Illinois, United States
Lexington, Kentucky, United States
Laguna Hills, California, United States
Des Moines, Iowa, United States
Kalispell, Montana, United States
Dallas, Texas, United States
Mount Sterling, Kentucky, United States
Lebanon, New Hampshire, United States
Nashua, New Hampshire, United States
Wyoming, Michigan, United States
Grand Rapids, Michigan, United States
Muskegon, Michigan, United States
Nampa, Idaho, United States
Danville, Illinois, United States
Boone, Iowa, United States
Fort Dodge, Iowa, United States
Jefferson, Iowa, United States
Marshalltown, Iowa, United States
Ames, Iowa, United States
Merced, California, United States
Minocqua, Wisconsin, United States
Ankeny, Iowa, United States
Sunset Hills, Missouri, United States
Niles, Michigan, United States
Reed City, Michigan, United States
Saint Joseph, Michigan, United States
O'fallon, Illinois, United States
Des Moines, Iowa, United States
Clive, Iowa, United States
Carmichael, California, United States
Grand Rapids, Michigan, United States
Saint Joseph, Michigan, United States
Silverdale, Washington, United States
Saint Johnsbury, Vermont, United States
Grand Rapids, Michigan, United States
Sandpoint, Idaho, United States
Baker City, Oregon, United States
Ontario, Oregon, United States
Irvine, California, United States
Kalamazoo, Michigan, United States
Havre, Montana, United States
Westminster, Colorado, United States
Ankeny, Iowa, United States
Clive, Iowa, United States
Des Moines, Iowa, United States
Des Moines, Iowa, United States
Aiea, Hawaii, United States
Aiea, Hawaii, United States
Aiea, Hawaii, United States
Ewa Beach, Hawaii, United States
Waukee, Iowa, United States
Cape Girardeau, Missouri, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported